Skip to main content
. 2011 Oct 28;81(4):281–286. doi: 10.4174/jkss.2011.81.4.281

Fig. 4.

Fig. 4

Immunostaining of tumor. p53 and Ki-67 immunostaining (×100; A, B, common bile duct cancer; C, D, gallbladder cancer) and K-ras mutation analysis (E).